相关实验视频

Updated: Jul 6, 2025

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection

Published on: December 8, 2014

便微生物群移植作为欧洲国家的新兴治疗方法 2.0

Serena Porcari^1,2, Marcello Maida³, Stefano Bibbò^1,2

¹Department of Medical and Surgical Sciences, Digestive Disease Center, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.

Advances in experimental medicine and biology

|January 4, 2024

概括

便微生物种移植 (FMT) 有效治疗复发性Clostridioides difficile感染 (CDI) 并显示出对炎症性肠病 (IBD) 的承诺. 本综述强调了欧洲关于这些疾病的FMT的研究.

科学领域:

胃肠病学胃肠病学
微生物学微生物学
免疫学免疫学免疫学

背景情况:

困难菌感染 (CDI) 是一种常见的,严重的与医疗相关的感染.
对CDI的抗生素治疗可能是无效的,导致复发.
肠道微生物群的改变与CDI和炎症性肠病 (IBD) 有关.

研究的目的:

审查便微生物群移植 (FMT) 治疗CDI和IBD的疗效.
要总结在欧洲国家进行的FMT研究.
探索FMT作为肠道微生物群相关疾病的治疗选择.

主要方法:

系统审查现有关于FMT的文献,用于CDI和IBD.
专注于在欧洲国家进行的研究.
对治愈率和治疗潜力的分析.

主要成果:

FMT显示了复发性CDI的高治愈率.
目前正在对IBD进行研究,正在进行的研究正在探索其治疗作用.
欧洲的研究正在为两种疾病的FMT数据做出重大贡献.

结论:

FMT是一种高度有效的治疗复发性CDI.
FMT有可能成为IBD的未来治疗方法,这需要进一步的研究.
欧洲研究对于在胃肠道疾病中推进FMT应用至关重要.

关键词:

克洛斯特里迪奥伊德困难感染.便微生物群移植便微生物群移植炎症性肠病是一种炎症性肠病.活生生的生物治疗产品经常性的CDI.

更多相关视频

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model

Published on: April 6, 2022

Murine Fecal Isolation and Microbiota Transplantation

Murine Fecal Isolation and Microbiota Transplantation

Published on: May 26, 2023

相关概念视频

What is Monogastric Digestion?

What is Monogastric Digestion?

The human body contains a monogastric digestive system. In a monogastric digestive system, the stomach only contains one chamber in which it digests food. Several other animal species also have monogastric digestive systems, including pigs, horses, dogs, and birds. This chapter, however, focuses on the human digestive system.